Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. [electronic resource]
Producer: 20150313Description: 22-32 p. digitalISSN:- 1528-0020
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- B-Lymphocytes -- cytology
- Biomarkers, Tumor -- metabolism
- Clinical Trials as Topic
- Cyclophosphamide -- therapeutic use
- Doxorubicin -- therapeutic use
- Female
- Gene Expression Profiling
- Humans
- Lymphoma, Large B-Cell, Diffuse -- therapy
- Male
- Prednisone -- therapeutic use
- Prognosis
- Rituximab
- Salvage Therapy -- methods
- Time Factors
- Treatment Outcome
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.